Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome
sep. 2022
Martin, Hasselblatt, et al
American Journal of Surgical Pathology
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
sep. 2022
Lena, Blümel, et al
Cell Death and Disease
Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis
aug. 2022
Laura E., Schultz-Rogers, et al
Developmental Dynamics
Target Actionability Review
feb. 2022
Kaylee M., Keller, et al
European Journal of Cancer
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial
